Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

Defeat Diabetes
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708

New Diabetes Vision Treatment

Posted: Saturday, July 23, 2005



An international study led by a Joslin Diabetes Center scientist suggests a new treatment may be effective in reducing vision loss in diabetes patients.

Loss of vision among diabetics results from two primary conditions: diabetic retinopathy and diabetic macular edema. In diabetic retinopathy, tiny blood vessels in the retina become damaged, Joslin officials said. While early in the disease there are often no symptoms, over time new, abnormal blood vessels proliferate and bleed easily. If untreated, proliferative diabetic retinopathy can cause severe vision loss.

In diabetic macular edema, leaky blood vessels cause swelling in the macula -- the part of the retina responsible for central vision.

The double-masked, randomized multiple-dose study involving 252 patients was conducted in the United States, Canada, Denmark, the Netherlands and Britain. It suggested RBX may reduce the risk of moderate vision loss caused by macular edema.

Source: Diabetes In

Join us on Facebook

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708


DDF advertisement

 Friendly Banner

Friendly Banner
Analyze nutrition content by portion
DDF advertisement